Corporate News
Notice of Results & Investor Presentation via Investor Meet Company
31 July 2025
Cambridge Nutritional Sciences plc (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it will publish its Final Results for the year ended 31 March 2025 on Tuesday, 19 August 2025.
Investor Presentation:
On the same day at 14:30 BST, James Cooper (Chief Executive Officer) and Ajay Patel (Chief Financial Officer) will host a live online presentation via the Investor Meet Company ("IMC") platform to discuss the results.
The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via the IMC dashboard up until 09:00 BST on 18 August 2025, or during the live event.
To register for the event and add Cambridge Nutritional Sciences plc to your watchlist, please visit:
https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor
Shareholders who already follow Cambridge Nutritional Sciences plc on the IMC platform will be automatically invited to the presentation.
Contacts:
Cambridge Nutritional Sciences plc | ||
Carolyn Rand, Non-Executive Chair | ||
James Cooper, Chief Executive Officer | ||
Ajay Patel, Chief Financial Officer | ||
Cavendish Capital Markets Limited |
Tel: 020 7220 0500 | |
Geoff Nash / Edward Whiley / (Corporate Finance) | ||
Nigel Birks / Harriet Ward (ECM) | ||
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
